Company profile
Biocure Technology Inc.
OTC: BICTF · Healthcare · Biotechnology
Canadian filerHQ Vancouver, BCReports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH 67DQ —GM —SS 24
v0.1 · 35/100 weight · pillars only
↑ balance-sheet leverage, return on assets · ↓ workforce scale, market scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$73.5k
Employees
3
as of 2026-08-27
Market cap
$379.1k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2025
Net income-$73.5k-102.8k CAD2025
Operating income-$64.9k-90.8k CAD2025
Total assets$1.5M2.0M CAD2025
Liabilities$317.1k434.7k CAD2025
Equity$1.1M1.6M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Biocure Technology Inc.’s revenue?
Biocure Technology Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Pond Technologies Holdings Inc.21DAlternative Energy Partners, Inc.——Actavia Life Sciences, Inc.——Marijuana Inc.——Bakhu Holdings, Corp.——Planet Based Foods Global Inc.37DKey facts
CEOYee Sing Cheng
SectorHealthcare
IndustryBiotechnology
HeadquartersVancouver, BC
ExchangeOTC: BICTF
Employees3
IPO date2018-11-28
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.